Ignite Creation Date:
2024-05-06 @ 3:57 PM
Last Modification Date:
2024-10-26 @ 2:00 PM
Study NCT ID:
NCT04811560
Status:
RECRUITING
Last Update Posted:
2024-05-23
First Post:
2021-03-22
Brief Title:
A Phase 12 Study of Bleximenib in Participants With Acute Leukemia
Sponsor:
Janssen Research Development LLC
Organization:
Janssen Research Development LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-19
Start Date Type:
ACTUAL
Primary Completion Date:
2026-02-16
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-02-16
Completion Date Type:
ESTIMATED
First Submit Date:
2021-03-22
First Submit QC Date:
March 22 2021
Study First Post Date:
2021-03-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-08
Last Update Post Date:
2024-05-23
Last Update Post Date Type:
ACTUAL